STOCK TITAN

MicroVision (NASDAQ: MVIS) director gets 22,007 shares from vested RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MICROVISION, INC. director Robert Paul Carlile reported the vesting of restricted stock units that were settled in common stock. On this Form 4, 22,007 Restricted Stock Units converted into 22,007 shares of common stock at a stated price of $0.00 per share, reflecting a compensation-related equity award rather than an open-market trade. After this distribution, he directly holds 560,706 shares of common stock. Footnotes explain that the RSUs convert on a unit-for-share basis and clarify that a prior Form 4 had misstated the total RSUs granted, with the current vesting calculated using the corrected grant amount.

Positive

  • None.

Negative

  • None.
Insider Carlile Robert Paul
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 22,007 $0.00 --
Exercise Common Stock 22,007 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 560,706 shares (Direct, null)
Footnotes (1)
  1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis. At vesting, converts into shares of common stock on a unit-for-share basis. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.
RSUs converted 22,007 units Restricted Stock Units converted to common stock
Common shares received 22,007 shares Shares of common stock issued upon RSU vesting
Price per share $0.00 per share Stated transaction price for RSU-to-share conversion
Shares owned after transaction 560,706 shares Total direct common stock holdings after RSU distribution
Exercise transactions 1 transaction Count of derivative exercises in this Form 4
Exercised derivative shares 22,007 shares Shares underlying derivative security exercised (RSUs)
Restricted Stock Units financial
"Vested restricted stock units, or RSUs, were distributed to the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Vested restricted stock units, or RSUs, were distributed to the Reporting Person"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
unit-for-share basis financial
"distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis"
Annual Meeting of Stockholders financial
"until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Carlile Robert Paul

(Last)(First)(Middle)
18390 NE 68TH STREET

(Street)
REDMOND WASHINGTON 98052

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/05/2026M22,007A$0.00(1)560,706D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units$0.00(2)06/05/2026M22,00706/05/2026(3)06/05/2026(3)Common stock22,007$0.000D
Explanation of Responses:
1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
2. At vesting, converts into shares of common stock on a unit-for-share basis.
3. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date. The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.
/s/ Drew G. Markham, attorney-in-fact for Robert Paul Carlile06/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Robert Paul Carlile report on the latest MicroVision (MVIS) Form 4?

Robert Paul Carlile reported the vesting of Restricted Stock Units that were settled in common stock. 22,007 RSUs converted into 22,007 common shares, reflecting a compensation-related equity distribution rather than an open-market purchase or sale.

How many MicroVision (MVIS) shares did Carlile receive in this Form 4 filing?

Carlile received 22,007 shares of MicroVision common stock through RSU vesting. Each Restricted Stock Unit converted into one share, with a stated transaction price of $0.00 per share, consistent with equity compensation rather than cash-funded market buying.

What are Robert Paul Carlile’s MicroVision (MVIS) holdings after this RSU vesting?

Following the RSU conversion, Carlile directly holds 560,706 shares of MicroVision common stock. This updated figure reflects the newly distributed 22,007 shares from vested RSUs in addition to his prior holdings shown in this Form 4 filing.

Was there any open-market buying or selling of MicroVision (MVIS) shares in this Form 4?

The Form 4 does not show open-market buying or selling. It reports an “M” code transaction, indicating exercise or conversion of a derivative security, where vested RSUs were distributed as common stock at a stated price of $0.00 per share.

What do the footnotes in Carlile’s MicroVision (MVIS) Form 4 explain about the RSUs?

The footnotes state that vested RSUs were distributed as common stock on a unit-for-share basis and outline the scheduled vesting terms. They also note that a prior Form 4 misreported the total RSUs granted, and that vesting here uses the corrected grant amount.

Does the MicroVision (MVIS) Form 4 indicate remaining derivative positions for Carlile?

The Form 4 data show 22,007 RSUs converted into common stock and a derivative balance of zero for that award. The derivative summary is empty, indicating no remaining RSUs from this specific grant visible in the filing after the reported vesting event.